Impaired osteoblast function in GPRC6A null mice

Journal of Bone and Mineral Research

Volumn 25, Issue 5, 2010, Pages 1092-1102

  Pi, Min ^a   Zhang, Lishu ^b,c   Lei, Shu Feng ^c   Huang, Min Zhao ^a   Zhu, Wenyu ^a   Zhang, Jianghong ^d   Shen, Hui ^c   Deng, Hong Wen ^b,c   Quarles, L Darryl ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BEIJING JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Bone mineral density; G Protein coupled Receptor (GPCR); Gene polymorphisms; GPRC6A; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; OSTEOPROTEGERIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW; BONE MINERALIZATION; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CYTOLOGY; DNA POLYMORPHISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; EXTRACELLULAR CALCIUM; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GPRC6A GENE; HISTOPATHOLOGY; HUMAN; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CELL LINE; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; OSTEOBLASTS; OSTEOCALCIN; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; STROMAL CELLS;

EID: 77953508447     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091037     Document Type: Article

References (45)

1. Kuang D, Yao Y, Lam J, Tsushima RG, Hampson DR. Cloning and characterization of a family C orphan G protein-coupled receptor. J Neurochem. 2005;93:383-391. (Pubitemid 40547495)
2. Wellendorph P, Hansen KB, Balsgaard A, Greenwood JR, Egebjerg J, Brauner-Osborne H. Deorphanization of GPRC6A: a promiscuous L-α-amino acid receptor with preference for basic amino acids. Mol Pharmacol. 2005;67:589-597. (Pubitemid 40365305)
3. Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G protein-coupled receptor. Gene. 2004;335:37-46. (Pubitemid 38759751)
4. Pi M, Faber P, Ekema G, et al. Identification of a novel extracellular cation-sensing G protein-coupled receptor. J Biol Chem. 2005;280:40201-40209. (Pubitemid 41779157)
5. Harno E, Edwards G, Geraghty AR, et al. Evidence for the presence of GPRC6A receptors in rat mesenteric arteries. Cell Calcium. 2008;44:210-219.
6. Pi M, Chen L, Huang MZ, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS ONE. 2008;3:e3858.
7. Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139-46.
8. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005;11:76-81. (Pubitemid 40193486)
9. Bucay N, Sarosi I, Dunstan CR, et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-8. (Pubitemid 28213402)
10. Hoff AO, Catala-Lehnen P, Thomas PM, et al. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest. 2002;110:1849-57. (Pubitemid 36076492)
11. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988;175:266-76.
12. Bonjour JP, Ammann P, Chevalley T, Rizzoli R. Protein intake and bone growth. Can J Appl Physiol. 2001;26 Suppl: S153-66.
13. Adibi SA, Mercer DW. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest. 1973;52:1586-94.
14. Shalhoub V, Grisanti M, Padagas J, et al. In vitro studies with the calcimimetic cinacalcet HCl on normal human adult osteoblastic and osteoclastic cells. Crit Rev Eukaryot Gene Expr. 2003;13:89-106.
15. Pi M, Garner SC, Flannery P, Spurney RF, Quarles LD. Sensing of extracellular cations in CasR-deficient osteoblasts: evidence for a novel cation-sensing mechanism. J Biol Chem. 2000;275:3256-63. (Pubitemid 30083026)
16. Wellendorph P, Johansen LD, Jensen AA, et al. No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions. J Mol Endocrinol. 2009;42:215-23.
17. Xiao ZS, Simpson LG, Quarles LD. IRES-dependent translational control of Cbfa1/Runx2 expression. J Cell Biochem. 2003;88:493-505.
18. Tu Q, Pi M, Karsenty G, Simpson L, Liu S, Quarles LD. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest. 2003;111:1029-37. (Pubitemid 36397479)
19. Ecarot-Charrier B, Glorieux FH, van der Rest M, Pereira G. Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol. 1983;96:639-43. (Pubitemid 13131324)
20. Liu YJ, Liu XG, Wang L, et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008;17:1803-13. (Pubitemid 351791507)
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-5. (Pubitemid 40202029)
22. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225-9.
23. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74:765-9.
24. Pi M, Quarles LD. Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors. J Cell Biochem. 2005;95:1081-92.
25. Niu T, Rosen CJ. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene. 2005;361:38-56.
26. Reim NS, Breig B, Stahr K, et al. Cortical bone loss in androgen-deficient aged male rats is mainly caused by increased endocortical bone remodeling. J Bone Miner Res. 2008;23:694-704.
27. Dvorak MM, Siddiqua A, Ward DT, et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A. 2004;101:5140-5.
28. Chang W, Tu C, Chen TH, Bikle D, Shoback D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal. 2008;1:ra1.
29. Yamaguchi T, Sugimoto T. [Impaired bone mineralization in calcium-sensing receptor (CaSR) knockout mice: the physiological action of CaSR in bone microenvironments]. Clin Calcium. 2007;17:1567-73.
30. Garner SC, Pi M, Tu Q, Quarles LD. Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology. 2001;142:3996-4005.
31. Boldyreff B, Wehling M. Rapid aldosterone actions: from the membrane to signaling cascades to gene transcription and physiological effects. J Steroid Biochem Mol Biol. 2003;85:375-81. (Pubitemid 37011113)
32. Fromigue O, Hay E, Barbara A, et al. Calcium sensing receptor-dependent and -independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med. 2009.
33. Oda Y, Tu CL, Pillai S, Bikle DD. The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem. 1998;273:23344-52. (Pubitemid 28417522)
34. Oda Y, Tu CL, Chang W, et al. The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation. J Biol Chem. 2000;275:1183-90. (Pubitemid 30051170)
35. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.Osteoporos Int. 1992;2:128-34.
36. Giannini S, Nobile M, Sella S, Dalle Carbonare L. Bone disease in primary hypercalciuria. Crit Rev Clin Lab Sci. 2005;42:229-48.
37. Hsiao EC, Boudignon BM, Chang WC, et al. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci U S A. 2008;105:1209-14.
38. Morley P, Whitfield JF, Willick GE. Design and applications of parathyroid hormone analogues. Curr Med Chem. 1999;6:1095-106. (Pubitemid 29496042)
39. Lau KH, Baylink DJ. Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res. 1998;13:1660-7.
40. Xie H, Tang SY, Cui RR, et al. Apelin and its receptor are expressed in human osteoblasts. Regul Pept. 2006;134:118-25.
41. Ofek O, Karsak M, Leclerc N, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A. 2006;103:696-701.
42. Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci. 2001;22:368-76.
43. Ho C, Conner DA, Pollak MR, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet. 1995;11:389-94.
44. Rohrer DK, Kobilka BK. G protein-coupled receptors: functional and mechanistic insights through altered gene expression. Physiol Rev. 1998;78:35-52.
45. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-69.